For in vitro ILC differentiation, sorted CLPs or αLPs (1 × 106 cells per well) were cocultured with OP9-DL1 cells [pretreated with mitomycin C (50 ng/ml) for 25 min] in complete Dulbecco’s minimum essential medium (DMEM) in the presence of cytokines in six-well plates. Recombinant murine IL-7, stem cell factor (SCF), and IL-15 (all 20 ng/ml) were used for ILC1 differentiation. IL-7, SCF, and IL-33 were used for ILC2 differentiation. IL-7, SCF, and IL-23 were used for ILC3 differentiation in six-well plates. Half of the culture medium was replaced every 3 days, and cultured cells were harvested on days 10 to 12. When indicated, Stat3 inhibitor VI (100 μM; Santa Cruz Biotechnology), Stat5 inhibitor (200 μM; Cayman Chemical), and Stat6 inhibitor (250 nM; Cayman Chemical, AS1517499) were added to the culture.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.